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Abstract: The effects of repeated halothane
anaesthesia on 6-10 week old male, Mus
musculus albino mice weighing 29-32 g were
studied. Halothane, a widely used
anaesthetic, is known to be metabolised in
the liver to toxic intermediates through
cytochrome P4502E1 (CYP2E1). During the
first week of repeated dosage, glucose-6phosphate dehydrogenase (G6PDH) activity
decreased in both erythrocytes and liver cells,
and during this time, livers increased
significantly in weight and suffered
histopathological damage, the damage
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Introduction
Halothane, 2-bromo-2 chloro-1-1-trifluoroethane,
has been used widely as an inhaled anaesthetic since 1957
(1). It is well established that halothane is metabolised in
the liver as a lipophilic xenobiotic to hepatotoxic
intermediates by monooxygenases through the
cytochrome P4502E1 system (CYP2E1) (2,3). Thus,
halothane anaesthesia causes hepatocellular necrosis,
destruction of the lipid-protein interactions in human
erythrocyte membranes, decrease in the activities of
membrane enzymes and alteration of cerebral glucose-6phosphate dehydrogenase (E.C.1.1.1.49, G6PDH)
activities (4). G6PDH, a key regulatory enzyme of the
pentose phosphate pathway, furnishes the reduced
nicotinamide adenine dinucleotide phosphate (NADPH)
used by the CYP2E1 system. Free radicals generated
during oxidative stress are quenched by such antioxidants
as glutathione (GSH) and antioxidant enzymes, the final
electron acceptor being NADPH. Thus, G6PDH activity
can be used as a biomarker to probe the effects of
detoxification on anaesthesia.
In order to gain further insight, we explore the effects
of repeated anaesthesia by halothane on mice, especially
on their livers. The investigation emphasizes

increasing with the dosage of halothane, in
the range 0.25-1.0 ml twice daily. When
repeated anaesthesia was continued for a
second week, G6PDH activity increased
significantly and histopathological damage to
the liver showed no further increase. Human
and mouse G6PDH show homology, and
further work to examine the parameters
controlling the eventual increase of enzyme
activity in response to insult by halothane and
its metabolites would be worthwhile.
Key Words: Halothane, G6PDH, RBC, liver.

measurements of G6PDH activity since human and mouse
G6PDH enzymes show homology (5).
Materials and Methods
Forty-five male, non-inbred, albino Mus musculus
mice, 6-10 weeks old, weighing between 29 and 33 g,
were obtained from the Medical Sciences Experimental
Research Center of Cukurova University. The animals
were divided into three groups: a control group of fifteen
apparently normal mice, and groups I and II, consisting of
fifteen mice each, which were repeatedly anaesthetised
with halothane for 1 or 2 weeks, respectively. According
to the volume of halothane inhaled on each occasion,
groups I and II were subdivided into three subgroups: a,
b and c, with 0.25 ml, 0.50 ml and 1.00 ml, respectively.
Inhalation persisted for 30 minutes at 0800 and 1600
hours, daily. Throughout the experiment all mice were
given tap water and a standard laboratory diet. The room
temperature was maintained at 22-24°C and the
illumination (12 hour light\dark cycle) was constant.
Blood was extracted from the tail vein and, after
anaesthesia, from the heart. The mice were weighed and
sacrificed. The livers were quickly removed, weighed and
homogenised with three volumes of ice-cold 0.25 M
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sucrose. The activity of G6PDH enzyme was measured in
the supernatant obtained from centrifugation at 105,000
g.
Enzyme activity was determined at 37°C both in the
homogenate and in the hemolysate according to the
procedure of Beutler (6). Protein concentrations were
measured using bovine serum albumin as the standard (7)
and
hemoglobin
was
determined
by
the
cyanomethemoglobin method (6).
Liver tissues were fixed in 10% formaldehyde and
embedded in paraffin. Five micrometer sections were
obtained, stained with Harris hematoxylene-eosin and
examined under a light microscope (8).
All chemicals used in enzyme assays were analytical
grade and were from the Sigma Chemical Company (St.
Louis, MO, USA).
Results
Superficially, repeated anaesthesia, even for two
weeks, had no obvious effect on either the activity or the
health of the mice. Microscopic examination (Figure)
showed specific morphological damage to have been
caused to liver tissues during the first week of exposure
to halothane, the extent of the damage increasing with
the dosage of the anaesthetic. Eosinophilic leucocytes and
mononuclear inflammatory cell infiltration of the portal
tractus were observed in the livers of three mice (one in
subgroup Ia, two in subgroup Ib). Nineteen livers
suffered cloudy degenerations, congestions, micro and
macro vesicular fatty degeneration, spotty necrosis and
centrilobular necrosis of the parenchymal cells. Liver
damage persisted but did not increase further in the
second week of repeated anaesthesia.
Whereas anaesthesia had no significant effect on the
total body weight (P>0.05) of the mice, it did increase

the weight of the livers significantly, except in subgroup
IIc (Table 1). The distinction between biochemical and
physiological response to halothane in the first and
second weeks of repeated anaesthesia is shown by the
measured activities of G6PDH. Table 2 shows the G6PDH
activity of erythrocytes to have decreased significantly
during the first week of repeated anaesthesia but to have
returned to the ‘control’ value by the second week and
increased significantly in the highest dosage. The same
phenomenon for G6PDH in the mouse liver is shown in
Table 2. Repeated anaesthesia with dosages of 0.5 or 1.0
ml of halothane for 1 week reduced the enzyme activity
by a factor of two or three, but during the second week
of repeated anaesthesia G6PDH activity returned to at
least its control value.
Discussion
Halothane is metabolised to hepatotoxic intermediates
by an oxidative CYP2E1 dependent pathway (2,3). The
biotransformation occurs through the generation of free
radicals, as has been shown by spin-trapping experiments
and electron spin resonance (9). In general, livers
increased in weight, as shown in Table 1. However, the
highest dosage and longer duration of exposure to
anaesthesia seemed to inhibit the increase. These results
are similar to the effects of ozone (10), which caused only
a slight decrease in the body weights of exposed mice, but
a significant increase in the weights of the lungs. G6PDH
activity decreased significantly both in the erythrocyte
and in the liver during the first week of exposure to
halothane, the magnitude of these changes in activity
paralleling the dose of the anaesthetic. G6PDH seems to
be utilized in the defense mechanism against the free
radical generated in the metabolism of halothane.
However, when exposure to halothane was continued for
a second week, enzyme activity returned to its normal
Table 1.

Groups

Control
*
Ia
*
Ib
*
Ic
*
IIa
*
IIb
IIc

n

15
5
5
5
5
5
5

Exposure
(week)

Dose
(ml 2x daily)

Liver weights (g)
X±SD

range

0
1
1
1
2
2
2

0
0.25
0.50
1.00
0.25
0.50
1.00

1.37±0.10
2.00±0.32
2.17±0.47
1.98±0.31
2.79±0.66
2.13±0.54
1.54±0.26

1.02-1.75
1.56-2.36
1.67-2.71
1.70-2.42
2.23-3.93
1.53-2.98
1.31-1.99

* Livers of anaesthetised mice weighed significantly more (p<0.05) than livers of controls except
subgroup IIc (Mann-Whitney-U test).
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Liver weights in control
and anaesthetised mice.
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Groups

RBC G6PDH activities
U/g Hb
(X±SD)

Control

32.4±7.7

U/mg protein
(X±SD)

RBC and liver G6PDH
activities of control and
anaesthetised mice.

0.036±0.017

Figure 1.

Liver tissue taken from
anaesthetised group (IIC) of
Mus musculus albino
mouse
(HematoxyleneEosin.
x200).
K:
congestion, Y: micro and
macro vesicular fatty
degeneration.

U/g liver
(X±SD)
1.756±0.814

Halothane 1 week
Ia (0.25 ml)
Ib (0.50 ml)
Ic (1.00 ml)

*

22.6±9.5
25.3±8.7
*
20.0±11.6

*

*

Halothane 2 weeks
IIa (0.25 ml)
IIb (0.50 ml)
IIc (1.00 ml)

35.4±3.8
39.8±3.4
+42.4±3.2

+0.052±0.037
0.039±0.011
0.028±0.008

+

*

Table 2.
Liver G6PDH activities

0.030±0.016
0.017±0.009
*
0.011±0.004

1.621±1.006
0.546±0.241
*
0.533±0.194

3.239±0.756
2.498±1.193
1.840±0.832

+

* RBC and liver G6PDH activities decreased significantly in the first week of anaesthesia
compared to control group (p<0.05) (Mann-Whitney-U test).
+ RBC and liver G6PDH activities increased significantly in the second week of anaesthesia
compared to control group (p<0.05) (Mann-Whitney-U test).

value. Indeed, during the second week of repeated
anaesthesia, G6PDH activity in the liver expressed as units
per g of liver appeared to exceed the control value,
suggesting that the synthesis of enzymes in the liver may
have been increased. This is entirely consistent with the
previous works of Caneghem (11) and Ankrah (12), who
showed that phenylhydrazine and aflatoxin B1 caused
temporary induction of G6PDH activity in mouse liver.

These results illustrate the ‘fine’ and ‘coarse control’
of G6PDH. G6PDH is a regulatory enzyme showing endproduct inhibition and deinhibition by the
phospho/dephospho mechanism, the NADPH/NADP ratio,
the GSSG/GSH ratio and protein attachment/deattachment
to the cellular membrane (13). Thus in the erythrocyte
any of these mechanisms would control the free radical
assault. However, in the liver, in order to adapt to the life-
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threatening attack, the ‘coarse control’, which responds
to such external stimuli as hormones, growth factors,
nutrients and oxidant stress, promotes the increased
synthesis of enzymes (13,14).
Damage to liver cells occurred during the first week of
repeated anaesthesia whilst G6PDH activity was lowered.
During the second week, though damage persisted,
induction of G6PDH was observed. Further work to
examine the parameters controlling the delay in induction
would be worthwhile.
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